ADIM
PCTY icon

Alpha DNA Investment Management’s Paylocity PCTY Stock Holding History

Alpha DNA Investment Management’s Portfolio PCTY Stock Details PCTY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,094
Closed -$418K – 126
2024
Q4 		$418K Buy
+2,094
New +$401K 0.16% 164
2024
Q3 		– Sell
-3,172
Closed -$418K – 242
2024
Q2 		$418K Buy
+3,172
New +$491K 0.16% 148
2023
Q2 		– Sell
-5,884
Closed -$1.17M – 207
2023
Q1 		$1.17M Buy
5,884
+400
+7% +$78.7K 0.35% 65
2022
Q4 		$1.07M Buy
+5,484
New +$1.18M 0.38% 96
2021
Q4 		– Sell
-5,093
Closed -$1.43M – 137
2021
Q3 		$1.43M Sell
5,093
-2,502
-33% -$601K 0.97% 47
2021
Q2 		$1.45M Buy
+7,595
New +$1.37M 0.99% 52

Other funds holding PCTY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return

Alpha DNA Investment Management's PCTY Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Paylocity (PCTY) in Q1 2025, closing a stake of 2,094 shares — an estimated $418K sold.

Alpha DNA Investment Management first reported a position in PCTY in Q2 2021 and held it in 6 quarters. The position peaked at $1.45M in Q2 2021. 468 funds tracked by Wall St. Rank hold PCTY as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Paylocity position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 2,094 Paylocity shares in Q1 2025, an estimated $418K.
  • Alpha DNA Investment Management first reported a position in Paylocity in Q2 2021 and held it in 6 quarters.
  • Alpha DNA Investment Management's Paylocity position peaked at $1.45M in Q2 2021.
  • 468 funds tracked by Wall St. Rank held Paylocity as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.